Thematic: Biotechnology
-
GeneralHealth is Wealth | How to Invest in this Game Changing Theme
In this Episode they share insights into a game-changing theme that they believe is a critical allocation within your portfolio; Health and Biotech.
23 February -
GeneralUncovered: Danimer Scientific (NYSE: DNMR)
We uncover Danimer Scientific, an American biotechnology company working to replace fossil-fuel based plastics with vegetable based bioplastics.10th Mar, 2023
-
GeneralThe search for a pill that can help dogs - and humans - live longer
This article from Wired takes a look at the history of trying to extend animal life, and how Loyal is trying to build on this work.28th Oct, 2022
-
GeneralFour investing megatrends
Megatrends are defined as macroeconomic changes we are seeing on a global scale that are transforming economies, businesses and societies. WAM Alternative Assets focuses on four key megatrends including: digitalisation, demographical shifts and ageing populations, climate change and the increasing demand for food.28th Sep, 2022
Source: Wilson Asset Management
-
Changing the lives of cancer patients - Dr Leslie Chong of Imugene | ASX CEO Connect Series
Dr Chong is the CEO and Managing Director of Imugene, an ASX-listed biotechnology company working to change the paradigm of cancer treatment - trading under the ASX ticker IMU. Dr Chong has over 20 years experience in leading clinical and department development in oncology including at major pharmaceutical companies Genentech, GSK and Roche.31 MarchSponsored by Australian Securities Exchange (ASX)
-
![Innovation in BioTech you need to be watching | w/ Michael Frazis]()
Innovation in BioTech you need to be watching | w/ Michael Frazis
Episode #112 of Equity Mates on AusBiz TV17 Sep, 2021
